TNF and rheumatoid arthritis: Most patients with RA were being actively treated with synthetic or biological disease modifying anti‐rheumatic drugs (DMARDs), most commonly combinations of methotrexate and/or leflunomide with an anti‐TNF agent, anti‐IL‐6‐receptor blocker, or other biological DMARD.